A Polymer-based Monolithic Capillary Column with Polymyxin-B Chiral Selector for the Enantioselective Nano-High Performance Liquid Chromatographic Pharmaceutical Analysis * , **

被引:13
|
作者
Ghanem, Ashraf [1 ]
Marzouk, Adel A. [2 ]
El-Adl, Sobhy M. [3 ]
Fouad, Ali [1 ,2 ]
机构
[1] Univ Canberra, Fac Sci & Technol, Chiral Program, Canberra, ACT 2601, Australia
[2] Al Azhar Univ, Fac Pharm, Pharmaceut Chem Dept, Assiut 71524, Egypt
[3] Zagazig Univ, Fac Pharm, Pharmaceut Chem Dept, Zagazig 44519, Egypt
关键词
Polymyxin-B; Monolith; Organic polymer; Enantio-separation; Encapsulation; Capillary; SILICA STATIONARY-PHASE; REVERSED-PHASE; MACROCYCLIC ANTIBIOTICS; SEPARATION; ELECTROCHROMATOGRAPHY; ENANTIOSEPARATION; HPLC; ENANTIOMERS; EREMOMYCIN; STABILITY;
D O I
10.1016/j.chroma.2021.462714
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Herein, we report the first use of Polymyxin-B antibiotic as a enantio-selector in polymer monolithic capillary. The capillaries were functionalised, characterized and tested for the enantioselective nanoHPLC separation of 50 racemic pharmaceutical drugs. They have been easily prepared by immobilizing Polymyxin-B over the organic polymer for 48 h (P1) or encapsulating Polymyxin-B within the organic polymer (P2) and tested for the enantioselective resolution of racemic drugs. Acceptable resolution was achieved for 21 drugs using RP-HPLC conditions on both (P1) and (P2) capillary columns, while no separation was observed under NP-HPLC conditions. Polymyxin-B is commercially available, easily solubilized and stable in both acidic and neutral media. The developed Polymyxin-B-based polymer monolithic capillaries provide a promising expansion of platform in enantioselective HPLC separations. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 12 条